Analyst Ratings for Prime Medicine (PRME)
PRME Rating Summary
PRME Price Target Summary
- Highest: $11.00 (Oppenheimer)
- Lowest: $4.25 (Citi)
- Average: $6.91
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.91 (+120.6%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Avg. $ Target:
$6.91 (+120.6%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | H.C. Wainwright » Updated 7/10/2026 |
Arthur He | Upgrade | Buy (Neutral) |
8.00 (N/A) |
3.43 (3.13) |
-8.75% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
5.00 (N/A) |
3.32 (3.13) |
-5.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
